UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
September 5, 2024
Accession Number:
0001213900-24-074542
Submission Type:
POS AM
CIK:
0001536196
Company Name:
Can-Fite BioPharma Ltd.
File Number:
333-259085